FMT for Postop Crohn's Disease

University of Minnesota23 enrolled

Overview

People with Crohn's disease often need surgery. The gut bacteria of people with Crohn's is associated with Crohn's disease coming back after surgery. Fecal microbiota transplant (FMT) after surgery might be a way to prevent Crohn's disease from coming back after surgery. This study aims to determine if fecal microbiota transplant (FMT) taken by capsules results in the same amount of good bacteria in the guts as FMT by colonoscopy in people with Crohn's disease who have had surgery. Participants will be randomized to get FMT by capsules or colonoscopy. Colonoscopy with biopsies 8-weeks after the FMT will be used to assess the good bacteria in the gut.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

BASIC_SCIENCE

Masking

SINGLE

Enrollment

Conditions

Crohn Disease

Interventions

Capsule fecal microbiota material (cap-FMT)BIOLOGICAL

Cap-FMT consists of Lyophilized FMT administered at 5 x 10\^11 bacteria per capsule daily for five days, for a total dose of 2.5 x 10\^12 bacteria.

Colonoscopic fecal microbiota material (colo-FMT)BIOLOGICAL

Colo-FMT consists of rehydrated Lyophilized FMT material administered as a single dose of 2.5 x 10\^12 bacteria as liquid.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Able and willing to sign informed consent form * Age 18 or older * English speaking * Established CD for at least 6-months based on typical clinical, endoscopic, and histopathic evidence. * Prior ileocecal resection for CD * Stable medications for 30 days * Women of reproductive age: Agree to remain abstinent or use effective birth control * Able and willing to comply with all study procedures Exclusion Criteria: * Antibiotic therapy within 15 days * Probiotic therapy within 15 days * Adenomatous polyps that have not been removed * Anticipated antibiotic use over the study period * Subtotal or total colectomy * Current ostomy (ileostomy or colonoscopy) * Anticipated surgical procedure over study period * Pregnancy * Severe food allergy * Diagnosis of end stage liver disease or cirrhosis * Absolute neutrophil count \< 500 cell / uL * Life expectancy \< 6 months

Locations (1)

University of Minnesota

Minneapolis, Minnesota, United States

Outcomes

Primary Outcomes

Ileal-associated microbiota engraftment

Microbiota community of the ileum as sampled by ileal biopsies from colonoscopy. We will use SourceTracker, a Bayesian community-wide software, to assess composition and donor similarity.

Time frame: 8 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.